- Home
- ORIC vs IDT Comparison
ORIC vs IDT Comparison
Compare ORIC & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | IDT |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ORIC | IDT |
|---|---|---|
| Price | $11.00 | $48.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $18.78 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 152.8K |
| Earning Date | 11-13-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 0.49% |
| EPS Growth | N/A | ★ 10.35 |
| EPS | N/A | ★ 3.22 |
| Revenue | N/A | ★ $1,244,681,000.00 |
| Revenue This Year | N/A | $0.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.15 |
| Revenue Growth | N/A | ★ 2.52 |
| 52 Week Low | $3.90 | $44.77 |
| 52 Week High | $14.93 | $71.12 |
Technical Indicators
Market Signals| Indicator | ORIC | IDT |
|---|---|---|
| Relative Strength Index (RSI) | 40.42 | 39.57 |
| Support Level | $10.45 | $48.96 |
| Resistance Level | $12.14 | $50.54 |
| Average True Range (ATR) | 0.77 | 1.63 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 26.05 | 4.60 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.